Preimplantation Genetic Testing for Cancer Survivors

Preimplantation genetic testing may help cancer survivors with inherited genetic variants reduce the risk of passing them on to their children. Learn how the procedure works, who may benefit, and why genetic counselling is essential.

Pregatips
Surviving cancer can bring new hope and the chance to plan for the future, including starting a family. However, some cancer survivors carry inherited genetic variants that increase their risk of developing certain cancers. They may also worry about passing these variants on to their children. Preimplantation genetic testing (PGT) offers one possible option for selected individuals.
Dr Chetna Jain, Director, Department of Obstetrics and Gynaecology at Cloudnine Group of Hospitals, Gurgaon, explains how the PGT procedure works, and survivors should consider it before deciding.

What is Preimplantation Genetic Testing?

Preimplantation genetic testing for monogenic conditions (PGT-M) is a specialised test used to identify specific inherited genetic variants in embryos created through in vitro fertilisation (IVF). It may be considered when one or both prospective parents carry a known variant associated with an inherited condition.

For example, certain variants in the BRCA1 and BRCA2 genes increase the risk of breast and ovarian cancers. PGT-M can help identify embryos that have not inherited the targeted variant. An embryo without the variant may then be considered for transfer into the uterus.

However, not every cancer survivor has an inherited cancer risk. PGT-M is appropriate only in selected cases where a suitable genetic testing strategy is available.

PGT-M offers selected cancer survivors an opportunity to reduce the risk of passing on inherited genetic variants. Genetic counselling helps families understand the benefits, limitations and available options.Dr Chetna Jain, Director, Department of Obstetrics and Gynaecology at Cloudnine Group of Hospitals, Gurgaon

How Does PGT-M Work?

PGT-M is done together with IVF, whereby certain steps are followed:

  • Genetic counselling: Your medical background, genetic history, and previous tests are reviewed to establish if PGT-M is appropriate
  • Ovarian stimulation: Fertility medications encourage the ovaries to produce several eggs
  • Egg retrieval and fertilisation: The eggs are retrieved and fertilised with sperm in the laboratory
  • Embryo culture: Embryos are formed from fertilised eggs after a week or two
  • Genetic diagnosis: Genetic tests are run to identify the genetic condition of the embryos
  • Embryo transfer: An embryo with no mutation is transferred back to the womb

Who May Benefit From PGT-M?

PGT-M may be suitable for cancer survivors carrying inherited genetic variants linked to certain cancers. It may be considered in the following situations:

  • People with BRCA1 or BRCA2 variants: Certain inherited changes in these genes increase the risk of breast, ovarian, and other cancers. PGT-M may help identify embryos that have not inherited the targeted variant
  • Individuals with Lynch Syndrome: This inherited condition increases the risk of colorectal, endometrial, and other cancers. PGT-M may help reduce the chance of passing the associated genetic variant to a child
  • People with Li-Fraumeni Syndrome: Certain inherited changes in the TP53 gene increase the risk of several cancers. These individuals may consider PGT-M after receiving genetic counselling
  • Couples with a confirmed hereditary cancer variant: When one partner carries a known cancer-related genetic variant, both partners can consult a clinical geneticist to understand inheritance risks and explore whether embryo testing is appropriate.
A fertility specialist can assess each person's medical history and reproductive goals before recommending suitable options.

How Can Cancer Treatment Affect Fertility?

Chemotherapy and radiotherapy may affect egg or sperm production and reduce fertility. Therefore, cancer survivors should discuss fertility preservation with their oncology team before treatment whenever possible.

Depending on your circumstances, options may include freezing eggs, sperm, or embryos for future use. Those who have completed cancer treatment can also consult a fertility specialist to assess their reproductive health and available options.

What Should Cancer Survivors Consider Before Choosing PGT-M?

Before proceeding, you should understand the procedure's limitations and practical considerations. Here's what you need to know:

  • Testing limitations: PGT-M cannot detect every possible genetic condition or guarantee that a child will never develop cancer
  • Financial costs: IVF and specialised genetic testing can involve significant expenses
  • Emotional considerations: Decisions about embryo testing and genetic risks can be challenging
  • Medical suitability: Previous cancer treatment and overall health may influence fertility treatment options
Dr Chetna Jain highlights the importance of genetic counselling to help individuals understand inheritance patterns, test results, and available reproductive choices.

Cancer survivors planning a family may consider preimplantation genetic testing if they carry a known inherited cancer-related variant. Consulting a fertility specialist or a clinical geneticist can help you understand whether PGT-M is suitable for your circumstances. Discussing fertility preservation before cancer treatment may also keep future options open. With appropriate counselling and medical guidance, survivors can make informed reproductive choices while understanding the benefits, limitations, and costs of testing.

FAQs on Preimplantation Genetic Testing for Cancer Survivors

  1. Does PGT-M examine embryos for all genetic disorders?
    No, PGT-M does not test embryos for all genetic disorders. It specifically looks for a known genetic variant linked to an inherited condition. Additional genetic tests may be needed to assess other conditions, depending on the family's medical history and individual circumstances.
  2. Is it possible for both partners to receive genetic testing before starting IVF?
    Yes, both partners can undergo genetic testing before starting IVF. Testing may help identify inherited genetic variants that could affect their children. A clinical geneticist can recommend suitable tests based on their medical histories, family backgrounds, and reproductive goals.
  3. Can cancer survivors with hereditary cancer mutations conceive naturally?
    Yes, cancer survivors with hereditary cancer mutations can often conceive naturally. However, they should consult a clinical geneticist to understand the chances of passing the variant to their children. Genetic counselling can help them explore reproductive options, including PGT-M, before making informed family-planning decisions.
How we reviewed this article
Our team continuously monitors the health and wellness space to create relevant content for you. Every article is reviewed by medical experts to ensure accuracy.